Novo Nordisk Ltd. (pharmaceutical industry)

BRAC University Internship reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.

Detalhes bibliográficos
Autor principal: Matin, Md. Zubair
Outros Autores: Aziz, Dr. Mohammed Tareque
Formato: Internship report
Idioma:English
Publicado em: BRAC University 2016
Assuntos:
Acesso em linha:http://hdl.handle.net/10361/6613
id 10361-6613
record_format dspace
spelling 10361-66132019-09-30T03:15:12Z Novo Nordisk Ltd. (pharmaceutical industry) Matin, Md. Zubair Aziz, Dr. Mohammed Tareque BRAC Business School, BRAC University Novo Nordisk Ltd. Diabetes Diabetes Association of Bangladesh (BADAS) Changing Diabetes Barometer (CDB) BRAC University Internship reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Cataloged from PDF version of Internship report. Includes bibliographical references (page 23). Bangladesh is a densely populated country situated at South- East Asia. Although the geographical area of the country is not that big, but the country is huge (8th in the world) in terms of the population (close to 160 million). Considering diabetes under the health sector, 5.9 million people have diabetes today and that would rise to 16.6 million by 2030. Per capita health expenditure is 152 DKK which is 3.7% of the GDP. To combat the disease, groups and institutions are serving through different public and private hospitals. Besides, Diabetes Association of Bangladesh (BADAS) is playing a crucial role. Everyday more than 12,000 patients are served by them through different DAB centres, National Health Care Network (NHN) centres, Health Care Development Project (HCDP) centres around the country. This altogether constitutes a complete and integrated diabetes care management system in the country. Having this world class diabetes care infrastructure in place, only 25% patients have access to treatment and within that 25% also the treatment outcome needs further improvement. There is an urgent need for change, which can be brought in through the Changing Diabetes® Barometer (CDB) and Novo Care Project. Md. Zubair Matin B. Business Administration 2016-10-19T09:22:46Z 2016-10-19T09:22:46Z 2016 2016-08-20 Internship report ID 13264059 http://hdl.handle.net/10361/6613 en BRAC University Internship reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 23 pages application/pdf BRAC University
institution Brac University
collection Institutional Repository
language English
topic Novo Nordisk Ltd.
Diabetes
Diabetes Association of Bangladesh (BADAS)
Changing Diabetes Barometer (CDB)
spellingShingle Novo Nordisk Ltd.
Diabetes
Diabetes Association of Bangladesh (BADAS)
Changing Diabetes Barometer (CDB)
Matin, Md. Zubair
Novo Nordisk Ltd. (pharmaceutical industry)
description BRAC University Internship reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
author2 Aziz, Dr. Mohammed Tareque
author_facet Aziz, Dr. Mohammed Tareque
Matin, Md. Zubair
format Internship report
author Matin, Md. Zubair
author_sort Matin, Md. Zubair
title Novo Nordisk Ltd. (pharmaceutical industry)
title_short Novo Nordisk Ltd. (pharmaceutical industry)
title_full Novo Nordisk Ltd. (pharmaceutical industry)
title_fullStr Novo Nordisk Ltd. (pharmaceutical industry)
title_full_unstemmed Novo Nordisk Ltd. (pharmaceutical industry)
title_sort novo nordisk ltd. (pharmaceutical industry)
publisher BRAC University
publishDate 2016
url http://hdl.handle.net/10361/6613
work_keys_str_mv AT matinmdzubair novonordiskltdpharmaceuticalindustry
_version_ 1814309332563525632